Cytisin amidophosphate--the new cytoprotector

Center for Life Sciences, Nazarbayev University, Kabanbay batyr ave. 53, Astana, Republic of Kazakhstan.
Hiroshima journal of medical sciences 09/2012; 61(3):45-9.
Source: PubMed


This article describes the results of a clinical study of O,O dimethyl-N-cytinizylphosphate in healthy volunteers and 142 patients with the verified diagnosis of acute toxic hepatitis. The tolerability was good. The efficiency of the drug is considered to be very high, normalization of the state took less time in comparison with standard treatment; a significant improvement was achieved immediately after the first injection.

16 Reads